COVID-19 and Lung Cancer – news and resources

Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report from the TERAVOLT Analysis

From JTO Clinical and Research Reports BRIEF REPORT| VOLUME 3, ISSUE 8, 100335, AUGUST 01, 2022 Authors: Christine M. Bestvina, MD Jennifer G. Whisenant, PhD Valter Torri, MD Marina Chiara Garassino, MD Javier Baena, MD On behalf of theTERAVOLT study group Show all authors Open Access Published: May 19, 2022 DOI: https://doi.org/10.1016/j.jtocrr.2022.100335 Introduction The Thoracic Centers International coronavirus […]

Impact of Coronavirus Pandemic on Global Lung Cancer Clinical Trials – paper published in JTO

Key recommendations from report to address urgent issue From Dr Eugene Manley, Director, Scientific Programs Lung Cancer Research Foundation 19 January 2022 I am excited to share the news that the co-authored publication, “Impact of Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer’’ has been […]

COVID-19 – New GLCC factsheets

The GLCC has developed two factsheets to address issues related to COVID-19 and lung cancer. The first of these new resources is the COVID-19 and LUNG CANCER FACTSHEET. The second factsheet deals with differentiating between the symptoms of COVID-19 and lung cancer. They are both available here, in English and 16 other languages, and can be downloaded as […]

COVID-19 – WEF / LAA report warns impact has pushed lung cancer services back 20 years’

During the World Economic Forum (WEF) this week, the Lung Ambition Alliance and WEF launched a new report: Learning Lessons from across Europe: Prioritizing Lung Cancer after Covid-19. The report calls upon governments to urgently restore lung cancer diagnosis and treatment to reduce further avoidable deaths. Lung cancer is the leading cause of cancer death […]

COVID-19 – UKLCC report

A report compiled by the UK Lung Cancer Coalition highlights the severe impact the coronavirus pandemic and the subsequent lockdown has had on the NHS and people living with lung cancer. It states that the number of people urgently referred to a lung cancer specialist dropped by 75% during the first wave of the Covid-19 […]

COVID-19 – Findings from our 2020 patient survey

Impact of COVID-19: findings from the 2020 GLCC members survey Patient advocacy and support organisations like the members of the GLCC engage with thousands of patients worldwide. Our members are working hard to support lung cancer patients through the COVID-19 pandemic and, in some cases, doing this with decreased resources. It is essential that policymakers […]